FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer

The FDA has approved alectinib to treat patients with metastatic ALK-positive non-small cell lung cancer who have stopped responding to...

Breast Cancer: Causes and Prevention

Cancer has been one of the leading illnesses in our present time. In fact, in the latest report from Reuters,...

Novel Treatment Approach Shrinks Ovarian Tumors in Mice

Researchers have developed a new approach for treating tumors that express mutant versions of the p53 protein, which are present...

Video Intervention Helps Prepare Patients to Participate in Cancer Clinical Trials

Patients who took part in a tailored, video-based educational program had a better understanding of and fewer concerns about participating...

Opportunities in Cancer Nanotechnology: A Conversation with NCI’s Dr. Piotr Grodzinski

The director of NCI’s Office of Cancer Nanotechnology Research discusses the Cancer Nanotechnology Plan 2015, as well as new developments...

NCI-MATCH: A Status Report and Future Directions

Leaders of the NCI-MATCH trial provide an update to the cancer community on the trial’s status and plans for it...

The ‘Crisis’ of Low HPV Vaccination Rates: A Conversation with Dr. Noel Brewer

Following the release of a consensus statement from the NCI-Designated Cancer Centers urging HPV vaccination in the United States, Dr....

Tackling the Global Cancer Burden: A Conversation with NCI’s Dr. Ted Trimble

In honor of World Cancer Day, the director of NCI’s Center for Global Health discusses key opportunities in global cancer...

Persistent Peripheral Neuropathy Increases Fall Risk among Cancer Survivors

Many female cancer survivors have problems with mobility and other physical functioning as a result of persistent peripheral neuropathy caused...